Wellgistics Health, Inc. (WGRX) Revenue History
Annual and quarterly revenue from 2023 to 2024
Compound Annual Growth Rate (CAGR)
Loading revenue history...
WGRX Revenue Growth
Revenue Breakdown (FY 2024)
WGRX's revenue distribution by segment and geography for fiscal year 2024
By Product/Segment
WGRX Revenue Analysis (2023–2024)
As of May 8, 2026, Wellgistics Health, Inc. (WGRX) generated trailing twelve-month (TTM) revenue of $5.6 million, reflecting significant decline in growth of -80.9% year-over-year. The most recent quarter (Q3 2025) recorded $3.0 million in revenue, down 61.3% sequentially.
Looking at the longer-term picture, WGRX's historical revenue data shows various trends over time. The company achieved its highest annual revenue of $18.1 million in 2024, representing a new all-time high.
Revenue diversification analysis shows WGRX's business is primarily driven by Product (100%). With over half of revenue concentrated in Product, the company maintains significant focus in this area while developing other growth vectors.
When compared to Healthcare sector peers including HSIC (+4.0% YoY), OMI (-41.0% YoY), and HCSG (+7.1% YoY), WGRX has underperformed the peer group in terms of revenue growth. Compare WGRX vs HSIC →
WGRX Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| WGRXCurrent | $6M | -80.9% | - | -33.9% | |
 HSIC | $13.2B | +4.0% | +5.4% | 5.7% | |
 OMI | $2.8B | -41.0% | -20.1% | 1.0% | |
 HCSG | $1.8B | +7.1% | +0.9% | 2.6% | |
 MCK | $359.1B | +12.4% | +9.2% | 1.2% | |
 CAH | $222.6B | +12.8% | +7.8% | 1.0% |
WGRX Historical Revenue Data (2023–2024)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | $18.1M | - | $1.8M | 9.7% | $-6,145,132 | -33.9% |
| 2023 | $0 | - | $0 | - | $-2,880,603 | - |
See WGRX's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs WGRX Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare WGRX vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonWGRX — Frequently Asked Questions
Quick answers to the most common questions about buying WGRX stock.
Is WGRX's revenue growth accelerating or slowing?
WGRX revenue declined -80.9% year-over-year, contrasting with the 5-year CAGR of N/A. TTM revenue fell to $6M. This reverses the prior growth trend.
What is WGRX's long-term revenue growth rate?
Wellgistics Health, Inc.'s 5-year revenue CAGR of N/A reflects the variable expansion pattern. Current YoY growth of -80.9% is below this long-term average.
How is WGRX's revenue distributed by segment?
WGRX reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2023-2024 are available for download. Segment mix reveals concentration and diversification trends.